Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users.

Major M, Gutfraind A, Shekhtman L, Cui Q, Kachko A, Cotler SJ, Hajarizadeh B, Sacks-Davis R, Page K, Boodram B, Dahari H.

Sci Transl Med. 2018 Jul 11;10(449). pii: eaao4496. doi: 10.1126/scitranslmed.aao4496.

PMID:
29997251
2.

Determinants in the Ig Variable Domain of Human HAVCR1 (TIM-1) Are Required To Enhance Hepatitis C Virus Entry.

Kachko A, Costafreda MI, Zubkova I, Jacques J, Takeda K, Wells F, Kaplan G, Major ME.

J Virol. 2018 Feb 26;92(6). pii: e01742-17. doi: 10.1128/JVI.01742-17. Print 2018 Mar 15.

3.

Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.

Tan WG, Zubkova I, Kachko A, Wells F, Adler H, Sutter G, Major ME.

PLoS One. 2017 Jul 21;12(7):e0181578. doi: 10.1371/journal.pone.0181578. eCollection 2017.

4.

Reverse Engineering of Vaccine Antigens Using High Throughput Sequencing-enhanced mRNA Display.

Guo N, Duan H, Kachko A, Krause BW, Major ME, Krause PR.

EBioMedicine. 2015 Jun 30;2(8):859-67. doi: 10.1016/j.ebiom.2015.06.021. eCollection 2015 Aug.

5.

Antibodies to an interfering epitope in hepatitis C virus E2 can mask vaccine-induced neutralizing activity.

Kachko A, Frey SE, Sirota L, Ray R, Wells F, Zubkova I, Zhang P, Major ME.

Hepatology. 2015 Dec;62(6):1670-82. doi: 10.1002/hep.28108. Epub 2015 Oct 16.

6.

Inhibition of hepatitis C virus by the cyanobacterial protein Microcystis viridis lectin: mechanistic differences between the high-mannose specific lectins MVL, CV-N, and GNA.

Kachko A, Loesgen S, Shahzad-Ul-Hussan S, Tan W, Zubkova I, Takeda K, Wells F, Rubin S, Bewley CA, Major ME.

Mol Pharm. 2013 Dec 2;10(12):4590-4602. doi: 10.1021/mp400399b. Epub 2013 Nov 7.

7.

Amino acid residue-specific neutralization and nonneutralization of hepatitis C virus by monoclonal antibodies to the E2 protein.

Duan H, Kachko A, Zhong L, Struble E, Pandey S, Yan H, Harman C, Virata-Theimer ML, Deng L, Zhao Z, Major M, Feinstone S, Zhang P.

J Virol. 2012 Dec;86(23):12686-94. doi: 10.1128/JVI.00994-12. Epub 2012 Sep 12.

8.

New neutralizing antibody epitopes in hepatitis C virus envelope glycoproteins are revealed by dissecting peptide recognition profiles.

Kachko A, Kochneva G, Sivolobova G, Grazhdantseva A, Lupan T, Zubkova I, Wells F, Merchlinsky M, Williams O, Watanabe H, Ivanova A, Shvalov A, Loktev V, Netesov S, Major ME.

Vaccine. 2011 Dec 9;30(1):69-77. doi: 10.1016/j.vaccine.2011.10.045. Epub 2011 Oct 29.

PMID:
22041300
9.

Genetic factors of Ebola virus virulence in guinea pigs.

Subbotina E, Dadaeva A, Kachko A, Chepurnov A.

Virus Res. 2010 Oct;153(1):121-33. doi: 10.1016/j.virusres.2010.07.015. Epub 2010 Jul 21.

PMID:
20654661
10.

Characterization of glycoprotein E C-end of West Nile virus and evaluation of its interaction force with alphaVbeta3 integrin as putative cellular receptor.

Bogachek MV, Zaitsev BN, Sekatskii SK, Protopopova EV, Ternovoi VA, Ivanova AV, Kachko AV, Ivanisenko VA, Dietler G, Loktev VB.

Biochemistry (Mosc). 2010 Apr;75(4):472-80.

PMID:
20618137
11.

T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation.

Zubkova I, Choi YH, Chang E, Pirollo K, Uren T, Watanabe H, Wells F, Kachko A, Krawczynski K, Major ME.

Vaccine. 2009 Apr 28;27(19):2594-602. doi: 10.1016/j.vaccine.2009.02.045. Epub 2009 Feb 24.

PMID:
19428866
12.

Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity.

Zhang P, Zhong L, Struble EB, Watanabe H, Kachko A, Mihalik K, Virata-Theimer ML, Alter HJ, Feinstone S, Major M.

Proc Natl Acad Sci U S A. 2009 May 5;106(18):7537-41. doi: 10.1073/pnas.0902749106. Epub 2009 Apr 20.

13.

A computational-experimental approach to designing a polyfunctional genosensor derived from the Escherichia coli gene yfiA promoter.

Tikunova NV, Khlebodarova TM, Kachko AV, Stepanenko IL, Kolchanov NA.

Dokl Biochem Biophys. 2007 Nov-Dec;417:357-61. No abstract available.

PMID:
18274460
14.

[Cellular laminin-binding protein and Venezuelan equine encephalomyelitis virus replication in Vero, 293 and 9S2 cells].

Gridina MM, Protopopova EV, Kachko AV, Ivanova AV, Bondarenko EI, Loktev VB.

Tsitologiia. 2007;49(11):966-72. Russian.

PMID:
18217364
15.

Application of bioinformatics resources for genosensor design.

Khlebodarova TM, Tikunova NV, Kachko AV, Stepanenko IL, Podkolodny NL, Kolchanov NA.

J Bioinform Comput Biol. 2007 Apr;5(2B):507-20.

PMID:
17636858
16.

[Immunochemical properties of West Nile virus protein prM and protein M C-end].

Bogachek MV, Protopopova EV, Ternovoĭ VA, Kachko AV, Ivanova AV, Ivanisenko VA, Shvalov AN, Loktev VB.

Mol Biol (Mosk). 2007 Jan-Feb;41(1):8-17. Russian.

PMID:
17380886
17.

Inhibition of West Nile virus replication by short interfering RNAs.

Kachko AV, Ivanova AV, Protopopova EV, Netesov V, Loktev VB.

Dokl Biochem Biophys. 2006 Sep-Oct;410:260-2. No abstract available.

PMID:
17286097
18.

[The properties of Ebola virus proteins].

Subbotina EL, Kachko AV, Chepurnov AA.

Vopr Virusol. 2006 Nov-Dec;51(6):4-10. Review. Russian.

PMID:
17214074
19.

[Immunochemical properties of short recombinant polypeptides of proteine of, the West Nile virus bearing epitopes of domains I and II].

Bogachek MV, Protopopova EV, Ternovoĭ VA, Kachko AV, Ivanova AV, Ivanisenko VA, Loktev VB.

Mol Biol (Mosk). 2005 Sep-Oct;39(5):813-22. Russian.

PMID:
16240715
20.

Neutralizing monoclonal antibodies against Russian strain of the West Nile virus.

Razumov IA, Kazachinskaia EI, Ternovoi VA, Protopopova EV, Galkina IV, Gromashevskii VL, Prilipov AG, Kachko AV, Ivanova AV, L'vov DK, Loktev VB.

Viral Immunol. 2005;18(3):558-68.

PMID:
16212535
21.

[The occurrence rate of HGV/GBV-C RNA and risk factors in patients of narcological dispensary in Novosibirsk].

Kachko AV, Ershov AE, Gavrilova IV, Shustov AV, Kochneva GV, Sivolobova GF, Grazhdantseva AA, Bukin VN, Komissarova MA, Netesov SV.

Zh Mikrobiol Epidemiol Immunobiol. 2005 Mar-Apr;(2):25-30. Russian.

PMID:
15881934
22.

[Activation of the RIG-I gene, coding for DEXH/D-protein in infection of RH cells by tick-borne encephalitis virus].

Monastyrskaia GS, Kostina MB, Filiukova OB, Protopopova EV, Konovalova SN, Kachko AV, Nikolaev LG, Loktev VB, Sverdlov ED.

Bioorg Khim. 2004 Mar-Apr;30(2):146-50. Russian.

PMID:
15143669
23.

[Possibilities of culturing mutant variants of Ade12 adenoviruses in 293 cell culture].

Sergeev AN, Petrishchenko VA, P'iankov OV, Shishkina LN, Sergeev AA, Kachko AV, Kiselev NN, Ternovoĭ VA, Sviatchenko VA.

Vopr Virusol. 2003 Nov-Dec;48(6):30-3. Russian.

PMID:
14708228
24.

[Laminin-binding protein (LBP) as a cellular receptor for the virus of Venezuelan equine encephalomyelitis (VEE): Part 1. A study of the interaction between VEE virus virions and the human recombinant LBP].

Bondarenko EI, Protopopova EV, Konovalova SN, Sorokin AV, Kachko AV, Surovtsev IV, Loktev VB.

Mol Gen Mikrobiol Virusol. 2003;(4):36-9. Russian.

PMID:
14664162
25.

[Variants of adenovirus type 5 with deletions in early genes: ability for selective replication in p53-defective human tumor cells].

Kachko AV, Sviatchenko VA, Ternovoĭ VA, Kiselev NN, Sorokin AV, Kiselev SL, Georgiev GP, Netesov SV.

Mol Biol (Mosk). 2003 Sep-Oct;37(5):868-75. Russian.

PMID:
14593924
26.

[Late activation of interferon-induced genes IFI-54k and IFI-56k in human RH cells infected with tick-borne encephalitis virus].

Gavrilov BG, Monastyrskaia GS, Velikodvorskaia TV, Filiukova OB, Konovalova SN, Kachko AA, Protopopova EV, Nikolaev LG, Loktev VB, Sverdlov ED.

Bioorg Khim. 2003 Mar-Apr;29(2):175-80. Russian.

PMID:
12708317
27.

Mapping of two dominant sites of VP35 of Marburg virus.

Sorokin AV, Kazachinskaia EI, Ivanova AV, Kachko AV, Netesov SV, Bukreyev AA, Loktev VB, Razumov IA.

Viral Immunol. 2002;15(3):481-92.

PMID:
12479397
28.

Induction of alternatively spliced spermidine/spermine N1-acetyltransferase mRNA in the human kidney cells infected by venezuelan equine encephalitis and tick-borne encephalitis viruses.

Nikiforova NN, Velikodvorskaja TV, Kachko AV, Nikolaev LG, Monastyrskaya GS, Lukyanov SA, Konovalova SN, Protopopova EV, Svyatchenko VA, Kiselev NN, Loktev VB, Sverdlov ED.

Virology. 2002 Jun 5;297(2):163-71.

29.

The study of transcription and replication of the Marburg virus using a minireplicon system constructed on the basis of viral genome [corrected].

Kachko AV, Sorokin AV, Belanov EF, Ivanova AV, Bukreyev AA, Collins P, Netesov SV.

Dokl Biochem Biophys. 2002 Mar-Apr;383:108-12. No abstract available. Erratum in: Dokl Biochem Biophys 2002 Jul-Aug;385:234.

PMID:
12058361
30.

[Comparative study of the morphology and antigenic properties of recombinant analogs of a Marburg virus nucleoprotein].

Kachko AV, Cheusova TB, Sorokin AV, Kazachinskaia EI, Cheshenko IO, Belanov EF, Bukreev AA, Ivanova AV, Razumov IA, Riabchikova EI, Netesov SV.

Mol Biol (Mosk). 2001 May-Jun;35(3):492-9. Russian.

PMID:
11443932
31.

Human recombinant laminin-binding protein: isolation, purification, and crystallization.

Sorokin AV, Mikhailov AM, Kachko AV, Protopopova EV, Konovalova SN, Andrianova ME, Netesov SV, Kornev AN, Loktev VB.

Biochemistry (Mosc). 2000 May;65(5):546-53.

32.

[Comparative study of the antigenic and immunogenic properties of native and recombinant Marburg virus VP35 proteins].

Sorokin AV, Kazachinskaia EI, Kachko AV, Ivanova AV, Bukreev AA, Razumov IA.

Vopr Virusol. 1999 Sep-Oct;44(5):206-13. Russian.

PMID:
10544447
33.

Kinetics of technetium-labeled heparin in hemodialyzed patients.

Majdalani G, Chomant J, Kachko A, Yanai M, Man NK.

Kidney Int Suppl. 1993 Jun;41:S131-4.

PMID:
8320906
34.

[Improving the quality of glass ocular prostheses].

Nadareĭshvili TB, Pakhomova TS, Labutina LV, Kachko AL.

Med Tekh. 1979 Nov-Dec;(6):23-7. Russian.

PMID:
514016

Supplemental Content

Loading ...
Support Center